WallStreetZenWallStreetZen

NASDAQ: VRDN
Viridian Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for VRDN

Based on 7 analysts offering 12 month price targets for Viridian Therapeutics Inc.
Min Forecast
$30.00+57.48%
Avg Forecast
$36.57+91.97%
Max Forecast
$40.00+109.97%

Should I buy or sell VRDN stock?

Based on 7 analysts offering ratings for Viridian Therapeutics Inc.
Buy
Strong Buy
1 analysts 14.29%
Buy
6 analysts 85.71%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their VRDN stock forecasts and price targets.

VRDN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-02-29
lockedlocked$00.00+00.00%2024-02-28
lockedlocked$00.00+00.00%2024-02-28
lockedlocked$00.00+00.00%2023-12-19
lockedlocked$00.00+00.00%2023-12-14
JMP Securities
Top 20%
81
BuyMaintains$38.00+99.48%2023-11-14
Stifel Nicolaus
Top 16%
85
Strong BuyReiterates$40.00+109.97%2023-09-13

1 of 1

Forecast return on equity

Is VRDN forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
34.53%

Forecast return on assets

Is VRDN forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

VRDN revenue forecast

What is VRDN's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$495.0k+57.64%
Avg 2 year Forecast
$14.1M+4,400%
Avg 3 year Forecast
$74.0M+23,474.52%
VRDN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

VRDN revenue growth forecast

How is VRDN forecast to perform vs Biotechnology companies and vs the US market?
Company
504.83%
Industry
45.3%
Market
10.84%
VRDN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
VRDN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

VRDN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
VRDN$19.05$36.57+91.97%Buy
TVGN$7.82N/AN/A
MDXG$8.26$13.00+57.38%Strong Buy
TNGX$11.54$17.00+47.31%Strong Buy
BLTE$47.05$58.67+24.69%Strong Buy

Viridian Therapeutics Stock Forecast FAQ

Is Viridian Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 7 Wall Street analysts covering (NASDAQ: VRDN) stock is to Buy VRDN stock.

Out of 7 analysts, 1 (14.29%) are recommending VRDN as a Strong Buy, 6 (85.71%) are recommending VRDN as a Buy, 0 (0%) are recommending VRDN as a Hold, 0 (0%) are recommending VRDN as a Sell, and 0 (0%) are recommending VRDN as a Strong Sell.

If you're new to stock investing, here's how to buy Viridian Therapeutics stock.

What is VRDN's revenue growth forecast for 2024-2026?

(NASDAQ: VRDN) Viridian Therapeutics's forecast annual revenue growth rate of 504.83% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 45.3%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.84%.

Viridian Therapeutics's revenue in 2024 is $314,000.On average, 2 Wall Street analysts forecast VRDN's revenue for 2024 to be $31,069,947, with the lowest VRDN revenue forecast at $18,830,271, and the highest VRDN revenue forecast at $43,309,623. On average, 3 Wall Street analysts forecast VRDN's revenue for 2025 to be $886,905,764, with the lowest VRDN revenue forecast at $43,309,623, and the highest VRDN revenue forecast at $2,554,640,099.

In 2026, VRDN is forecast to generate $4,646,306,602 in revenue, with the lowest revenue forecast at $1,620,030,982 and the highest revenue forecast at $9,283,951,279.

What is VRDN's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: VRDN) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is VRDN's Price Target?

According to 7 Wall Street analysts that have issued a 1 year VRDN price target, the average VRDN price target is $36.57, with the highest VRDN stock price forecast at $40.00 and the lowest VRDN stock price forecast at $30.00.

On average, Wall Street analysts predict that Viridian Therapeutics's share price could reach $36.57 by Feb 28, 2025. The average Viridian Therapeutics stock price prediction forecasts a potential upside of 91.97% from the current VRDN share price of $19.05.

What is VRDN's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: VRDN) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.